€137.85
0.25% yesterday
Xetra, Dec 23, 05:40 pm CET
ISIN
DE0006599905
Symbol
MRK
Sector
Industry

Merck Stock price

€137.85
-5.10 3.57% 1M
-29.20 17.48% 6M
-6.25 4.34% YTD
-3.45 2.44% 1Y
-87.35 38.79% 3Y
+32.55 30.91% 5Y
+59.29 75.47% 10Y
Xetra, Closing price Mon, Dec 23 2024
-0.35 0.25%
ISIN
DE0006599905
Symbol
MRK
Sector
Industry

Key metrics

Market capitalization €59.93b
Enterprise Value €68.24b
P/E (TTM) P/E ratio 22.23
EV/FCF (TTM) EV/FCF 26.21
EV/Sales (TTM) EV/Sales 3.26
P/S ratio (TTM) P/S ratio 2.86
P/B ratio (TTM) P/B ratio 2.12
Dividend yield 1.60%
Last dividend (FY23) €2.20
Revenue growth (TTM) Revenue growth -2.17%
Revenue (TTM) Revenue €20.96b
EBIT (operating result TTM) EBIT €4.34b
Free Cash Flow (TTM) Free Cash Flow €2.60b
Cash position €3.16b
EPS (TTM) EPS €6.20
P/E forward 20.51
P/S forward 2.84
EV/Sales forward 3.23
Show more

Create a Free Account to create an Merck alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Merck Stock Analysis

Analyst Opinions

17 Analysts have issued a Merck forecast:

14x Buy
82%
3x Hold
18%

Analyst Opinions

17 Analysts have issued a Merck forecast:

Buy
82%
Hold
18%

Financial data from Merck

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
20,963 20,963
2% 2%
100%
- Direct Costs 8,679 8,679
1% 1%
41%
12,284 12,284
5% 5%
59%
- Selling and Administrative Expenses 3,438 3,438
9% 9%
16%
- Research and Development Expense 2,418 2,418
2% 2%
12%
6,428 6,428
3% 3%
31%
- Depreciation and Amortization 2,090 2,090
13% 13%
10%
EBIT (Operating Income) EBIT 4,338 4,338
9% 9%
21%
Net Profit 2,696 2,696
7% 7%
13%

In millions EUR.

Don't miss a Thing! We will send you all news about Merck directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Merck Stock News

AD HOC NEWS
8 days ago
Der Darmstädter Pharma- und Technologiekonzern Merck DE0006599905 stärkt sein Geschäft mit einer weiteren Übernahme.
AD HOC NEWS
about one month ago
Merck KGaA DE0006599905 lässt den Durchhänger nach dem Corona-Boom weiter hinter sich.
AD HOC NEWS
about one month ago
Die Schweizer Großbank UBS hat die Einstufung für Merck KGaA DE0006599905 nach Zahlen für das dritte Quartal auf "Buy" mit einem Kursziel von 190 Euro belassen.
More Merck News

Company Profile

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, and Performance Materials. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Head office Germany
CEO Belén López
Employees 62,908
Founded 1995
Website www.merckgroup.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today